"...OTHER THEN full disclosure prematurely is likely to result in material prejudice to 99 Wuxian's negotiating position and runs the risk of losing the transaction".
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025